Therapeutic efficacy of sacituzumab govitecan in recurrent refractory germ cell tumors.

Udvorková N, Blahová V, Malchárková P, Jochová S, Kaľavská K, Fekiačová A, Pavel J, Horák S, Džongov A, Janko J, Pastorek M, Chovanec M, Čierna Z, Mego M, Kučerová L

Open source

DOI: 10.1016/j.biopha.2025.118659
Published: 2025 Nov
Container: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.biopha.2025.118659,
  title = {Therapeutic efficacy of sacituzumab govitecan in recurrent refractory germ cell tumors.},
  author = {Udvorková N and Blahová V and Malchárková P and Jochová S and Kaľavská K and Fekiačová A and Pavel J and Horák S and Džongov A and Janko J and Pastorek M and Chovanec M and Čierna Z and Mego M and Kučerová L},
  year = {2025},
  journal = {Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie},
  doi = {10.1016/j.biopha.2025.118659},
  url = {https://doi.org/10.1016/j.biopha.2025.118659}
}

RIS

TY  - JOUR
TI  - Therapeutic efficacy of sacituzumab govitecan in recurrent refractory germ cell tumors.
AU  - Udvorková N
AU  - Blahová V
AU  - Malchárková P
AU  - Jochová S
AU  - Kaľavská K
AU  - Fekiačová A
AU  - Pavel J
AU  - Horák S
AU  - Džongov A
AU  - Janko J
AU  - Pastorek M
AU  - Chovanec M
AU  - Čierna Z
AU  - Mego M
AU  - Kučerová L
PY  - 2025
JO  - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
DO  - 10.1016/j.biopha.2025.118659
UR  - https://doi.org/10.1016/j.biopha.2025.118659
ER  -

APA

N, U., V, B., P, M., S, J., K, K., A, F., J, P., S, H., A, D., J, J., M, P., M, C., Z, Č., M, M., & L, K. (2025). Therapeutic efficacy of sacituzumab govitecan in recurrent refractory germ cell tumors.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. https://doi.org/10.1016/j.biopha.2025.118659

Source records

pubmed · retrieved 2026-09-27T15:36:24.238Z
europe-pmc · retrieved 2026-09-27T15:36:24.256Z